Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
Public ClinicalTrials.gov record NCT00447564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Probuphine in Patients With Opioid Dependence
Study identification
- NCT ID
- NCT00447564
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Titan Pharmaceuticals
- Industry
- Enrollment
- 163 participants
Conditions and interventions
Conditions
Interventions
- Probuphine Drug
- placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2006
- Primary completion
- Jun 30, 2008
- Completion
- Jun 30, 2008
- Last update posted
- Dec 30, 2018
2006 – 2008
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| David Geffen School of Medicine at UCLA | Los Angeles | California | 90025 | — |
| Synergy Clinical Research Center | National City | California | 91950 | — |
| North County Clinical Research | Oceanside | California | 92056 | — |
| Amit Vijapura, MD and Associates | Jacksonville | Florida | 32256 | — |
| Fidelity Clinical Research | Lauderhill | Florida | 33319 | — |
| Scientific Clinical Research, Inc | North Miami | Florida | 33161 | — |
| Northwest Behavioral Research Center | Roswell | Georgia | 30076 | — |
| Behavioral Biology Research Unit, Johns Hopkins Bayview Campus | Baltimore | Maryland | 21224 | — |
| Dual Diagnosis Unit, SSTAR: Stanley Street Treatment and Resources, Inc. | Fall River | Massachusetts | 02720-6009 | — |
| Wayne State University Department of Psychiatry and Behavioral Neurosciences | Detroit | Michigan | 48207 | — |
| Psych Care Consultants Research | St Louis | Missouri | 63128 | — |
| New York VA Medical Center, NYU School of Medicine | New York | New York | 10010 | — |
| Addiction Institute of New York | New York | New York | 10019 | — |
| Duke University Medical Center Addictions Program | Durham | North Carolina | 27705 | — |
| Pahl Pharmaceutical Research, LLC | Oklahoma City | Oklahoma | 73118 | — |
| University of Pennsylvania Treatment Research Center | Philadelphia | Pennsylvania | 19104 | — |
| Providence Behavioral Health Services | Everett | Washington | 98206 | — |
| Puget Sound Health Care Systems | Seattle | Washington | 98108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00447564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 30, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00447564 live on ClinicalTrials.gov.